X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

Grasp the opportunity at Emerging Markets for High Growth of Life Science and Chemical Instrumentation

Yuvraj_pawp by Yuvraj_pawp
20th February 2016
in Facilities & Operation

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The global life science and chemical instrumentation market will reach USD48.84 billion by 2019, with the compound average growth rate of 6.9%. Geographically, North America is the global largest life science and chemical instrumentation market, however, developing regions such as emerging countries in Asian-Pacific area will, with the highest rate of growth, be expected to become important strategic markets for analytical instrument manufacturers. In particular, countries represented by China, India and Singapore, where consistent growth of pharmaceutical industry, new investment of local government to national pharmaceutical and biopharmaceutical industry development have stimulated the growth of Chinese life science and chemical instrumentation market.

LABWorld China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM Sinoexpo, will be held on 21 – 23 June 2016 at Shanghai New International Expo Center. Thanks to ongoing collaboration of “CPhI & BioPh China 2016”, LABWorld China will offer a great opportunity to meet with over 20,000 R&C and C-level visitors from pharmaceutical, biopharmaceutical and new drug R&D enterprises at home and abroad,while establishing a trade platform for the broad instrument manufacturers to showcase the latest technologies and products, thus becoming a booster for the sound and stable development of Chinese scientific instrument industry.

Top instrument brands including Mettler-Toledo, Corning, Sartorius, Pall, DKSH, Anton Paar, Tegent, Buchi, Thermo Fisher, LAUDA, AkzoNobel, Genstech, Hanbon Sci. & Tech., Sinoinstrument, Lisure Science, and Hanguang Industry have confirmed to participate. During the show, buyers will be able to see the most advanced instruments and equipment in Chinese and foreign pharmaceutical, chemical, and biotechnological fields, such as biochemical and analytical instruments, laboratory equipment/corollary equipment, detecting instruments (industry specific), optical instruments, measuring (metering) instruments, laboratory consumables, and water purification products to be displayed at Hall N1 in Shanghai New International Expo Center. The exhibition will once again become an annual industry event for Chinese and foreign life science and chemical instrumentation.

 

 

 

The show will specially invite academic experts, researchers and international pharmaceutical enterprise R&D personnel in R&D field both, home and abroad,to provide the latest product consulting and technology optimization schemes.A number of high-end onsite events will be held during LABWorld China including the Pharmaceutical R&D Innovation and Outsourcing Management Conference, Laboratory Capacity Building Seminar, LABWorld enterprise technical exchange meeting, etc., to create and provide a powerful industrial and social platform to share the latest development information with the industry leaders.

Online visitor registration is now open! Please visit http://www.cphi.com/china to register or contact Ms. Tina Zheng (tina.zheng@ubmsinoexpo.com) for more information.

Previous Post

ICSE China 2016 – A gala event for pharma CRO & CMO industry

Next Post

NEX China 2016 to Set Sail by the "Healthy and Natural" Wind

Related Posts

API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
API Manufacturing Facility
Americas

Lilly to Build $6.5B API Manufacturing Facility in Houston

25th September 2025
Merck and Siemens
Drug Development

Merck and Siemens to Accelerate AI Driven Drug Development

24th September 2025
Scottish Pharma Sector
Europe

ABPI Launches Manifesto to Advance Scottish Pharma Sector

23rd September 2025
Automating Experimental Design with Generative AI in Pharma
Facilities & Operation

Automating Experimental Design with Generative AI in Pharma

20th September 2025
Next Post

NEX China 2016 to Set Sail by the "Healthy and Natural" Wind

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In